Trial intelligence / Profile preview

Aspirin (KARDEGIC) for intrauterine growth retardation in pregnancy

2011-003536-30Phase 4Active

Sponsor
CHRU Tours
Start
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of lysine acetylsalicylate in intrauterine growth restriction (IUGR) and Pregnancy-related complication, sponsored by CHRU Tours. Started Aug 2012; status: active.

02

Drugs

lysine acetylsalicylate
03

Conditions

intrauterine growth restriction (IUGR)Pregnancy-related complication

Beyond the preview

Go deeper on 2011-003536-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003536-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call